Bo Ying
Chief Executive Officer AboGen
Dr. Bo Ying is the founder and CEO of Abogen Biosciences, the leading mRNA company in China focused on developing innovative mRNA technologies for prophylactic vaccines, cancer and autoimmune diseases. Dr. Ying has many years of experiences in the development of nucleic acid-based therapeutics, and he has held various roles in leading biopharmaceutical companies in Boston. His work has been published in journals such as Cell, Lancet Microbe, Cell Research, and he is also the inventor of over 100 patents and patent applications.
Dr. Ying has a bachelor’s degree from Fudan University in China and a Ph.D. degree from Northeastern University in Boston.
Seminars
Thursday 29th January 2026
Unlocking the Therapeutic Power of Self-Amplifying & Circular RNA for Longer Expression and Lower Dosing
2:00 pm
- Discovering how saRNA and circRNA are redefining RNA’s potential with longer lasting expression, lower dosing, and expanded therapeutic applications
- Understanding the scientific and clinical implications of modality-specific challenges, from immunogenicity to delivery complexit
- Learning from pioneering case studies translating next-generation RNA formats into viable therapies across oncology, rare diseases, and beyond
